What is it about?

Helmut Baumgartner MD, chair of the ESC task force for the management of valvular heart disease talks about the changes to the updated Guidelines presented in August 2017 at the ESC Congress in Barcelona.

Featured Image

Why is it important?

The wealth of new data accumulated during the period since 2012, particularly on percutaneous interventional techniques, has required an urgent update of the previous Guidelines.


The new Guidelines also represent a break with the traditional format and readers will find the published version much shorter than usual in response to demand for brevity and content. Clear presentation and a summary of key points and existing gaps in evidence at the end of each section are designed for clarity and to focus on content.

Judith Ozkan

Read the Original

This page is a summary of: ESC Clinical Practice Guidelines on the Management of Valvular Heart Disease-2017 Update, European Heart Journal, September 2017, Oxford University Press (OUP), DOI: 10.1093/eurheartj/ehx470.
You can read the full text:




The following have contributed to this page